These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22695395)

  • 1. Developmental reprogramming of cancer susceptibility.
    Walker CL; Ho SM
    Nat Rev Cancer; 2012 Jun; 12(7):479-86. PubMed ID: 22695395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new paradigm of the developmental origin of health and diseases (DOHaD)--Epigenetics and environment: evidence and missing links].
    Junien C; Panchenko P; Pirola L; Amarger V; Kaeffer B; Parnet P; Torrisani J; Bolaños Jimenez F; Jammes H; Gabory A
    Med Sci (Paris); 2016 Jan; 32(1):27-34. PubMed ID: 26850604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epigenetics in transgenerational responses to environmental impacts: from facts and gaps].
    Junien C; Panchenko P; Fneich S; Pirola L; Chriett S; Amarger V; Kaeffer B; Parnet P; Torrisani J; Bolaños Jimenez F; Jammes H; Gabory A
    Med Sci (Paris); 2016 Jan; 32(1):35-44. PubMed ID: 26850605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic epidemiology of the developmental origins hypothesis.
    Waterland RA; Michels KB
    Annu Rev Nutr; 2007; 27():363-88. PubMed ID: 17465856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asking the right questions: how early-life exposures influence later development of disease.
    Barrett JR
    Environ Health Perspect; 2012 Oct; 120(10):a403. PubMed ID: 23026485
    [No Abstract]   [Full Text] [Related]  

  • 6. Epigenetics and life-long consequences of an adverse nutritional and diabetic intrauterine environment.
    El Hajj N; Schneider E; Lehnen H; Haaf T
    Reproduction; 2014 Dec; 148(6):R111-20. PubMed ID: 25187623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually Dimorphic Effects of Early-Life Exposures to Endocrine Disruptors: Sex-Specific Epigenetic Reprogramming as a Potential Mechanism.
    McCabe C; Anderson OS; Montrose L; Neier K; Dolinoy DC
    Curr Environ Health Rep; 2017 Dec; 4(4):426-438. PubMed ID: 28980159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The end of the beginning: epigenetic variation in utero as a mediator of later human health and disease.
    Mansell T; Saffery R
    Epigenomics; 2017 Mar; 9(3):217-221. PubMed ID: 28234019
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetics and DOHaD: from basics to birth and beyond.
    Bianco-Miotto T; Craig JM; Gasser YP; van Dijk SJ; Ozanne SE
    J Dev Orig Health Dis; 2017 Oct; 8(5):513-519. PubMed ID: 28889823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Carbon Metabolism and Lipid Metabolism in DOHaD.
    Fukuoka H; Kubota T
    Adv Exp Med Biol; 2018; 1012():3-9. PubMed ID: 29956189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic studies in Developmental Origins of Health and Disease: pitfalls and key considerations for study design and interpretation.
    Yamada L; Chong S
    J Dev Orig Health Dis; 2017 Feb; 8(1):30-43. PubMed ID: 27609592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic basis for fetal origins of age-related disease.
    Thompson RF; Einstein FH
    J Womens Health (Larchmt); 2010 Mar; 19(3):581-7. PubMed ID: 20136551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking the Epigenome with Exposure Effects and Susceptibility: The Epigenetic Seed and Soil Model.
    Bowers EC; McCullough SD
    Toxicol Sci; 2017 Feb; 155(2):302-314. PubMed ID: 28049737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting later-life outcomes of early-life exposures.
    Boekelheide K; Blumberg B; Chapin RE; Cote I; Graziano JH; Janesick A; Lane R; Lillycrop K; Myatt L; States JC; Thayer KA; Waalkes MP; Rogers JM
    Environ Health Perspect; 2012 Oct; 120(10):1353-61. PubMed ID: 22672778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood.
    Walker CL
    Birth Defects Res A Clin Mol Teratol; 2011 Aug; 91(8):666-71. PubMed ID: 21656660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preemptive Epigenetic Medicine Based on Fetal Programming.
    Kubota T
    Adv Exp Med Biol; 2018; 1012():85-95. PubMed ID: 29956197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics as the mediator of fetal programming of adult onset disease: what is the evidence?
    Saffery R; Novakovic B
    Acta Obstet Gynecol Scand; 2014 Nov; 93(11):1090-8. PubMed ID: 24835110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the in utero environment on the epigenome.
    Saffery R
    Epigenomics; 2017 Mar; 9(3):209-211. PubMed ID: 28234018
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetic mechanisms in fetal origins of health and disease.
    Osborne-Majnik A; Fu Q; Lane RH
    Clin Obstet Gynecol; 2013 Sep; 56(3):622-32. PubMed ID: 23787712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental Epigenetics in Children's Environmental Health.
    Marsit CJ
    Semin Reprod Med; 2016 Jan; 34(1):36-41. PubMed ID: 26696277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.